Key result
Shock team management linked to ~48% lower short-term mortality in cardiogenic shock.
Why the study?
Shock teams have been introduced to optimize cardiogenic shock care, but their clinical benefits remain unclear.
Does management by a shock team reduce short-term mortality in adults hospitalized with cardiogenic shock?
Systematic Review (n=1,526)
Does management by a shock team reduce short-term mortality in adults hospitalized with cardiogenic shock?
Multidisciplinary shock team management for cardiogenic shock may reduce short-term mortality and bleeding complications, though current evidence is limited to observational studies.
Answers are grounded in this paper and cite their sources.
Supports a multidisciplinary approach for cardiogenic shock; leaves open whether this observational survival benefit withstands.
Background: Recently, shock teams have been introduced to optimize cardiogenic shock (CS) care; however, their clinical benefits remain unclear. We conducted a systematic review and meta-analysis to assess whether management by a shock team improves outcomes in patients with CS. Methods and Results: This meta-analysis was conducted according to the PRISMA guidelines. Studies comparing adults with CS managed with or without a shock team were identified from the PubMed, Web of Science, and Cochrane Library databases. The primary outcome was short-term mortality (cardiac intensive care unit, in-hospital, or 30-day mortality); the secondary outcome was bleeding. Of the 7 retrospective cohort studies that met the inclusion criteria, 3 without a critical risk of bias were included in the analysis. Shock team management was significantly associated with lower short-term mortality (odds ratio [OR] 0.52; 95% confidence interval [CI] 0.32-0.85; P=0.010) and bleeding complications (OR 0.62; 95% CI 0.43-0.91; P=0.010). Sensitivity analysis using crude data also supported the mortality benefit (OR 0.68; 95% CI 0.54-0.85; P<0.010). However, no randomized trials were included, and the certainty of evidence was rated very low owing to the risk of bias and inconsistency. Conclusions: Shock team management may improve short-term outcomes in patients with CS; however, the level of evidence is very low. Further prospective studies are needed to evaluate optimal shock team composition and roles.
No takes yet. Share an insight, caveat, or question.
A 2025 study conducted a systematic review in Cardiogenic shock (n=1,526). Shock team management vs. No shock team management was evaluated on Short-term mortality (cardiac intensive care unit, in-hospital, or 30-day mortality) (OR 0.52, 95% CI 0.32-0.85, p=0.010). Shock team management was associated with lower short-term mortality compared to management without a shock team in patients with cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: